ARGX: שווי שוק לרווח נקי מותאם קצב צמיחה argenx SE

argenx SE relies on hybrid manufacturing via Western CMO partners to ensure supply stability. The peg_co multiple on GURU.Markets reflects the balance between price and earnings, with the current figure standing at 0.76. A team of elite immunologists is attracted by the freedom of research, yet the business remains dependent on a single drug while expanding its application across various pathologies.

The PEG ratio compares a stock's market value with its earnings growth rate, allowing for the determination of an asset's undervaluation relative to its expansion. By analyzing the P/E ratio against EPS dynamics, investors identify high-growth "rockets," which is critical for argenx SE (ARGX), where the robotization of antibody synthesis accelerates development, yet prolonged clinical trials create a time lag in monetization.